Ignite Creation Date:
2025-12-24 @ 4:25 PM
Ignite Modification Date:
2025-12-27 @ 7:32 PM
Study NCT ID:
NCT06159166
Status:
RECRUITING
Last Update Posted:
2025-04-23
First Post:
2023-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
Sponsor:
Johns Hopkins University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-02-12
Start Date Type:
ACTUAL
Primary Completion Date:
2027-11-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11-15
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-08
First Submit QC Date:
None
Study First Post Date:
2023-12-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-18
Last Update Post Date:
2025-04-23
Last Update Post Date Type:
ACTUAL